BATMAN-TCM: A Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Zhongyang ^a,b   Guo, Feifei ^c   Wang, Yong ^d   Li, Chun ^d   Zhang, Xinlei ^e   Li, Honglei ^e   Diao, Lihong ^a,b   Gu, Jiangyong ^f   Wang, Wei ^d   Li, Dong ^a,b   He, Fuchu ^a,b  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b BEIJING INSTITUTE OF LIFEOMICS   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e Beijing Genestone Technology Ltd   (China)

^f PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CHINESE MEDICINE; DRUG DEVELOPMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SIGNAL TRANSDUCTION; WEB BROWSER;

COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MEDICINE, CHINESE TRADITIONAL; REPRODUCIBILITY OF RESULTS; ROC CURVE; SIGNAL TRANSDUCTION; WEB BROWSER;

EID: 84958242317     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21146     Document Type: Article

References (56)

1. Cheung, F. TCM: made in China. Nature. 480, S82-S83 (2011).
2. Qiu, J. China plans to modernize traditional medicine. Nature. 446, 590-591 (2007).
3. Qiu, J. Traditional medicine: a culture in the balance. Nature. 448, 126-128 (2007).
4. The art and science of traditional medicine Part 1: TCM today-a case for integration. Science. 346, 1569 (2014).
5. Kong, D. X., Li, X. J., Zhang, H. Y. Where is the hope for drug discovery? Let history tell the future. Drug Discov. Today. 14, 115-119 (2009).
6. Xue, R. et al. TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids. Res. 41(Database issue), D1089-D1095 (2013).
7. Chen, X. et al. Database of traditional Chinese medicine and its application to studies of mechanism and toprescription validation. Br. J. Pharmacol. 149, 1092-1103 (2006).
8. Chen, C. Y. TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One. 6, e15939 (2011).
9. Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., Sharan, R. Combining drug and gene similarity measures for drug-target elucidation. J. Comput. Biol. 18, 133-145 (2011).
10. Zhao, S., Li, S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One. 5, e11764 (2010).
11. Cheng, T., Li, Q., Wang, Y., Bryant, S. H. Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining. J. Chem. Inf. Model. 51, 2440-2448 (2011).
12. Campillos, M., Kuhn, M., Gavin, A. C., Jensen, L. J., Bork, P. Drug target identification using side-effect similarity. Science. 321, 263-266 (2008).
13. Zhang, B., Wang, X., Li, S. An integrative platform of TCM network pharmacology and its application on a herbal formula, Qing-Luo-Yin. Evid. Based Complement. Alternat. Med. 2013, 456747 (2013).
14. Li, X. et al. A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PLoS One. 7, e43918 (2012).
15. Liu, H., Wang, J., Zhou, W., Wang, Y., Yang, L. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J. Ethnopharmacol. 146, 773-93 (2013).
16. Li, Y. et al. Investigation into the mechanism of Eucommia ulmoides Oliv. based on a systems pharmacology approach. J. Ethnopharmacol. 151, 452-460 (2014).
17. Wang, Y. et al. Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease. Evid. Based Complement. Alternat. Med. 2012, 698531 (2012).
18. Wang, Y. et al. DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4. BMC Complement. Altern. Med. 14, 67 (2014).
19. Yu, H. et al. A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. PLoS One. 7, e37608 (2012).
20. Ye, H. et al. HIT: linking herbal active ingredients to targets. Nucleic Acids Res. 39(Database issue), D1055-D1059 (2011).
21. Ru, J. et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 6, 13 (2014).
22. Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., Sharan, R. Combining drug and gene similarity measures for drug-target elucidation. J. Comput. Biol. 18, 133-145 (2011).
23. Yao, Y. et al. Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. J. Ethnopharmacol. 150, 619-638 (2013).
24. Hou, Y. Z. et al. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF). Trials. 14, 138 (2013).
25. Li, Y. C. et al. Attenuating effect of post-treatment with QiShen YiQi Pills on myocardial fibrosis in rat cardiachypertrophy. Clin. Hemorheol. Microcirc. 51, 177-191 (2012).
26. Tang, D. X. et al. QiShenYiQi Pills, a compound chinese medicine, ameliorates doxorubicin-induced myocardial structure damage and cardiac dysfunction in rats. Evid. Based Complement. Alternat. Med. 2013, 480597 (2013).
27. Xiao, P. et al. Modern Chinese Materia Medica (eds Xiao, P. et al.) Preface (Chemical Industry Press, 2007).
28. Tilley, D. G. et al. ?-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Circulation. 130, 1800-1811 (2014).
29. McKinney, C. A., Fattah, C., Loughrey, C. M., Milligan, G., Nicklin, S. A. Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling. Clin. Sci. (Lond). 126, 815-127 (2014).
30. Yang, Z. et al. Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation. 106, 106-111 (2002).
31. Lipskaia, L., Chemaly, E. R., Hadri, L., Lompre, A. M., Hajjar, R. J. Sarcoplasmic reticulum Ca(2+ ) ATPase as a therapeutic target for heart failure. Expert Opin. Biol. Ther. 10, 29-41 (2010).
32. McCormick, M. E., Rojas, M., Moser-Katz, T., Tzima, E., Reader, J. S. Natural aminoacyl tRNA synthetase fragment enhances cardiac function after myocardial infarction. PLoS One. 9, e109325 (2014).
33. Schmieder, R. E., Hilgers, K. F., Schlaich, M. P., Schmidt, B. M. Renin-angiotensin system and cardiovascular risk. Lancet. 369, 1208-19 (2007).
34. Wang, Y. et al. Cardioprotective effects of Qishenyiqi mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin-converting enzyme 2. Evid. Based Complement. Alternat. Med. 2012, 978127 (2012).
35. Qi, Y. et al. Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp. Physiol. 97, 89-101 (2012).
36. Guo, J. W. et al. Effects of Panax notoginseng saponins on ACE2 and TNF-alpha in rats with post-myocardial infarction-ventricular remodeling. Zhong Yao Cai. 33, 89-92 (2010).
37. Fang, C. et al. Total saponins of panax ginseng inhibiting human endothelium cells' damages induced by angiotensin II via AT1 receptor. J. Ethnopharmacol. 38, 439-44 (2011).
38. O'Boyle, N. M. et al. Open Babel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).
39. Haider, N. Functionality pattern matching as an efficient complementary structure/reaction search tool: an open-source approach. Molecules. 15, 5079-5092 (2010).
40. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
41. Ding, C., Peng, H. Minimum redundancy feature selection from microarray gene expression data. J. Bioinform. Comput. Biol. 3, 185-205 (2005).
42. Liu, Z. et al. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources. Bioinformatics. 31, 1788-95 (2015).
43. Wishart, D. S. et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36(Database issue), D901-D906 (2008).
44. Heller, S., McNaught, A., Stein, S., Tchekhovskoi, D., Pletnev, I. InChI-the worldwide chemical structure identifier standard. J. Cheminform. 5, 7 (2013).
45. Kuhn, M. et al. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 (2010).
46. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40(Database issue), D109-D114 (2012).
47. Cheng, J. et al. Evaluation of analytical methods for connectivity map data. Pac. Symp. Biocomput. 2013, 5-16 (2013).
48. Kuhn, M. et al. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 36, D684-D688 (2008).
49. UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 43(Database issue), D204-12 (2015).
50. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 43(Database issue), D6-17 (2015).
51. Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40(D1), D1128-1136 (2012).
52. Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F., Hamosh, A. OMIM.org: Online Mendelian Inheritance in Man (OMIM® ), an online catalog of human genes andgenetic disorders. Nucleic Acids Res. 43(Database issue), D789-98 (2015).
53. Benjamini, Y., Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 57, 289-300 (1995).
54. Luo, W., Brouwer, C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 29, 1830-1831 (2013).
55. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-504 (2003).
56. Spitzer, M., Wildenhain, J., Rappsilber, J., Tyers, M. BoxPlotR: a web tool for generation of box plots. Nat. Methods. 11, 121-122 (2014).